White Paper on Isolator Compliance The Baker Company recently concluded testing on their compounding aseptic isolators (CAIs) and compounding aseptic containment isolators (CACIs) to demonstrate compliance with the proposed USP <797> changes, which include a requirement for manufacturers to demonstrate that their CAIs and CACIs maintain ISO Class 5 internal cleanliness while located in an environment worse than ISO Class 7. Baker has prepared a white paper detailing the experimental process used to demonstrate compliance for its SterilSHIELD CAI and ChemoSHIELD CACI.
CLICK HERE to download the PDF of this full article (Adobe Acrobat™ 6.0+ required)
- 1 - 100
- 101 - 200
- 201 - 300
- 301 - 400
- 400+
- January 2012
Establish a Robust Drug Shortages Program - January 2012
Infection Control in the Cleanroom - January 2012
A Systematized Approach to Combat Drug Diversion - January 2012
Benefits of Temperature Monitoring Systems - January 2012 : Resource Guide
PP&P is proud to be the Information Clearinghouse of Choice for All Your Hospital Pharmacy Needs!

- In The Loop!
- Digital Edition
- Special Announcements









Our mission is to provide health system pharmacists with information to streamline pharmacy operations and promote patient safety.